Luna ʻepekema Nui
Wenqiang Yu, Ph.D.
●Luna ʻepekema Nui o ka Polokalamu "973" Lahui;
●Ua koho ʻia ʻo Polofesa no Chang Jiang Scholars Program;
●PI, Center for Epigenetics, Institute of Biomedical Sciences Fudan University;
●Ka mea noiʻi i koho ʻia a me ka Luna Nui o ke Kulanui o Fudan;
●Ke alakaʻi o ke Kōmike Hoʻonaʻauao Methylation Marker o ke Kōmike Tumor Marker o ka Hui Anti-Cancer Association.
I ka makahiki 1989, ua puka 'o ia mai ke Kulanui Lapa'au Koa 'Ehā a loa'a 'o ia i ke kēkelē laepua ma ka lā'au lapa'au;
I ka makahiki 2001, ua loaʻa iā ia ke kēkelē laepua mai ke Kulanui Lapaʻau Koa ʻEhā;
Mai 2001-2004, loaʻa ka Postdoctoral ma ka 'Oihana Hoʻomohala a me Genetics, ke Kulanui ʻo Uppsala, Suedena;
Mai 2004-2007, loaʻa ka Postdoctoral ma ke Kula Nui o ke Kulanui o Hopkins, ʻAmelika Hui Pū ʻIa;
I kēia manawa, ʻo Professor Yu ka PI a me ka hoa noiʻi o nā Institutes of Biomedical Sciences o Fudan University, a me ka Luna Hoʻokele Hoʻokele o ka Institute of Genomics and Epigenomics o Fudan University.Ua paʻi ʻia kāna mau hana noiʻi i loko o nā puke pai honua kiʻekiʻe e like me,ʻAno, Nature GeneticsaJAMA.
i hoʻopaʻa ʻia i loko o nā nūpepa hoʻonaʻauao kiʻekiʻe o ka honua e like me Nature, Nature Genetics a me JAMA, me ka hopena kiʻekiʻe loa o nā helu 38.1.
Luna Nui
Lin Hua
Bachelor of Economics o Shanghai JiaoKe Kulanui ʻo Tong.Ua hana ʻo ia ma ke ʻano he Luna Hoʻokele o ke Keʻena ʻOihana Hui Pū ʻIa o Guosen Securities, hoa o XIANGDU CAPITAL, ka hoa hoʻokumu o CHOBE CAPITAL.Ma ke ʻano he alakaʻi o ka hui, ua hoʻolaha ʻo ia e hoʻopukapuka kālā i nā ʻoihana kūleʻa.
ObiO(688238): CGT CDMO mea hana me ka mana nui loa;
Novoprotein(688137): mea hoʻolako maka e kālele ana i ka protein recombinant;
Leadsynbio: hui alakaʻi i ka biology synthetic;
SinoBay: nā ʻoihana lapaʻau maʻi maʻi
ʻO Quectel(603236): ʻo ka ʻoihana ʻoihana kelepona kelepona nui loa o ka honua
XinpelTek: e kālele ana i ka ʻoihana puʻupuʻu PA RF uila;
DGene: e nānā i ka ʻoihana kikohoʻe 3D
Video++: ʻoihana unicorn ma kahi o AI
Me ka ʻoi aku o hoʻokahi ʻumi makahiki ma ka mākeke kapikala, ua hōʻiliʻili ʻo Ms Hua i ka ʻike nui i ka hoʻokele ʻoihana a me ka hoʻopukapuka kālā.
Luna Hoʻokele R&D
Wei Li, Ph.D.
Ua hana ʻo Kauka Li ma ke ʻano he ʻimi noiʻi ma ke Kulanui o Biological Science Fudan University no ʻumi makahiki.Ua noho pelekikena ʻo ia ma luna o 3 mau papahana noiʻi me ka National Natural Science Foundation o Kina，ka papahana noiʻi kūʻokoʻa o ka hoʻokomo ʻana i nā kālenaa etc.Ua komo pū ʻo ia i kekahi mau papahana aupuni, me ka National 973 Project, Key Project of National Natural Science Foundation a pēlā aku.Ua paʻi ʻo ia i 16 mau pepa SCI ma ke ʻano he mea kākau mua a i ʻole mea kākau pili maNoiʻi Genome, eBiomedicine, Nuclear Acid Ka noiʻi a me nā mea ʻē aʻe.(Aggregate Impact Factor 158.97).
Nā makemake noiʻi nui:
1. Hoʻomohala ʻana i nā algorithm epigenetic a me nā haʻawina multi-omics o ka pathogenesis tumor.Ua hoʻokumu ʻia kahi hoʻonā kumu hoʻokahi o ka genome-wide DNA methylation sequencing analysis platform (WGPS algorithm) i ka wā mua.A laila ua loaʻa ka palapala mua o ka genome-wide DNA methylation o nā puʻupaʻa o ke kanaka.Eia nō naʻe, hāʻawi ʻo ia i kahi hana hou o ka tumor suppressor gene silencing i ka ʻike epigenetics.
2. E nānā i nā biomarkers maʻamau o ka hana ʻino i nā ʻano maʻi maʻi he nui e ka ʻikepili multi-omics.Ma muli o nā kaʻina WGPS, ua nānā mākou i nā māka hypermethylation kūikawā ma waena o nā ʻōpū a me ka maʻamau.
3. Ka noiʻi e pili ana i ka pathogenesis o ka gene transcriptional activation e NamiRNA: He papa o ka nuklea miRNA, a mākou i kapa ai ʻo NamiRNA (Nuclear Activating miRNA).
ʻEnekinia R&D Lapaʻau
Meigui Wang, Ph.D.
Ua loaʻa iā Kauka Wang kāna Ph.D.kēkelē mai ke Kulanui Lapaʻau Hema ma 2019. Ua alualu hou ʻo ia i kāna hoʻomaʻamaʻa hoʻonaʻauao kamaʻāina ma ka Halemai Hoʻohui ʻekolu o ke Kulanui ʻo Sun Yat-sen (2019-2021).ʻO kāna makemake lapaʻau i ka ʻike a me ka mālama ʻana i nā maʻi maʻi poʻo a me ka ʻāʻī e like me ka maʻi maʻi laryngeal a me ka carcinoma nasopharyngeal.ʻO kāna mau noiʻi makemake e nānā i ka ʻike mua ʻana o ka nasopharyngeal carcinoma.
ʻEnekinia R&D Lapaʻau
ʻO Yaping Dong, Ph.D.
Ua loaʻa iā Kauka Dong he Ph.D.kēkelē i nā lāʻau lapaʻau mai Fujian Medical University ma 2020, a ua alakaʻi i ka noiʻi post-doctoral ma Fudan University Shanghai Cancer center mai 2020 a 2022. Ma ke ʻano he mea nui, ua komo ʻo ia i kekahi mau National Projects, me ka Ministry of Science and Technology Key Program no " ʻO ka hoʻomohala ʻana i nā lāʻau lapaʻau hou nui", ka National Natural Science Foundation o Kina a pēlā aku.Ua paʻi ʻo ia i kekahi mau pepa kiʻekiʻe ma Acta Pharmaceutica Sinica B, Acta Pharmacologica Sinica a me Radiation Oncology.